Clinical application of double-capsule fecal catheter device in ICU patients with fecal incontinence: a single-center retrospective study across five years

Abstract Objective To explore the clinical effect and potential value of double-capsule fecal catheter device in patients with fecal incontinence in intensive care unit (ICU). Methods The double-capsule fecal catheter device in this study has been granted a utility model patent by the State Intellectual Property Office of the People’s Republic of China (Patent grant number: ZL201520691458.6) before its implementation. Design patents have been transformed into physical medical supplies and used in clinical and nursing practice. A total of 62 patients with fecal incontinence who were admitted to the ICU of the First Affiliated Hospital of Gannan Medical University from May 2017 to May 2022 were selected and randomly divided into the experimental group and the control group, with 32 cases in the experimental group and 30 cases in the control group. The experimental group was given a double-capsule fecal catheter device, and the control group was given an ordinary fecal catheter device for drainage. The catheter prolapse rate, catheter obstruction rate, stool leakage rate and prognostic value were compared between the two groups. Results The catheter prolapse rate, catheter obstruction rate, and stool leakage rate in the experimental group were significantly lower than those in the control group, and the difference was statistically significant ( P  < 0.01), and the length of hospital stay and prognostic indicators were better than those in the control group ( P  < 0.05). Conclusion The use of the newly developed double-capsule fecal catheter device can reduce the rate of catheter prolapse, catheter obstruction, and stool leakage in patients with fecal incontinence in the ICU. Correspondingly, patients with fecal incontinence who used the double-capsule fecal catheter device had shorter ICU days than those who did not, and it improved relevant prognostic indicators during the patient's hospitalization. It has good clinical practicability and popularity for fecal incontinence patients, and is worthy of use and promotion.